EPISODE · Sep 21, 2023 · 28 MIN
Data Collection
from The Business of Orthobiologics Podcast · host Ariana De Mers
Explore the nuances of leukocyte-rich and leukocyte-poor treatments, and don't forget to consider the role of monocytes. Plus, we'll unravel the mystery of dose calculation and how Patient Reported Outcomes impact registry data. Tune in now to stay ahead in the Orthobiologics game!Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.Learn More here: https://thebusinessoforthobiologics.com/programs-explanation _______________________________________________________Follow us and subscribe to our links below ⏬⏬⏬Website: businessoforthobiologics.comApple Podcast: apple.co/3Azvt3RSpotify: spoti.fi/3oICYmhYoutube: bit.ly/drariana
Embed this episode
What this episode covers
Explore the nuances of leukocyte-rich and leukocyte-poor treatments, and don't forget to consider the role of monocytes. Plus, we'll unravel the mystery of dose calculation and how Patient Reported Outcomes impact registry data. Tune in now to stay ahead in the Orthobiologics game! Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs ...
Ready to play
Data Collection
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.